GlassScriptPhysician profile
Naja Chisty
NPI 1205295359
$2,571.66
in general payments reported to CMS, 2019-2025
17 companies · $984 in 2025
The $984 reported for 2025 was more than what 77% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $219 · 2021: $233 · 2022: $368 · 2023: $301 · 2024: $466 · 2025: $984.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,751.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,750.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $460.27 | 2020-2024 | Clareon, Wavelight Refractive Suite |
| Tarsus Pharmaceuticals, INC. | $354.06 | 2024-2025 | Xdemvy |
| Bausch & Lomb Americas INC. | $269.02 | 2023-2025 | Miebo, Envista Envy Iol, Xiidra |
| Rxsight INC | $263.46 | 2022-2025 | Rxsight Contact Lens, Rxsight Injector Cartridge, Rxsight Injector Handpiece |
| Johnson & Johnson Surgical Vision, INC. | $222.21 | 2022-2025 | Tecnis Iol, Tecnis Iol |
| Harrow Eye, LLC | $188.42 | 2025 | Verkazia, Iheezo, Flarex |
| Oyster Point Pharma, INC. | $147.34 | 2022-2023 | Tyrvaya |
| Biotissue Holdings INC. | $140.75 | 2022-2023 | |
| Allergan, INC. | $131.58 | 2020 | |
| Astellas Pharma US INC | $102.60 | 2024 | Izervay |
| Nova Eye, INC. | $86.70 | 2025 | |
| New World Medical,INC. | $70.13 | 2023-2025 | Kahook Dual Blade, Ahmed Glaucoma Valve, Clearpath |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $43.93 | 2020 | |
| Abbvie INC. | $42.89 | 2023-2025 | Vuity, Lumigan, Alphagan P |
| Novartis Pharmaceuticals Corporation | $16.62 | 2023 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $16.52 | 2022 | |
| Horizon Therapeutics Plc | $15.16 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Naja Chisty listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.